Endolysins and Their Potential in Combating Bacterial Multidrug Resistance
Frontiers in Bioscience-Elite · 2026-06-01 · 18 (2)
DOI: 10.31083/fbe44070 ↗At a glance
Übersichtsarbeit in Frontiers in Bioscience-Elite, published online on 2026-06-01. Written by Olga I Guliy and 1 co-authors. Institution: Institute of Biochemistry and Physiology of Plants and Microorganisms - Subdivision of the Federal State Budgetary Research Institution Saratov Feder…. Major MEDLINE topics: Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents, Endopeptidases. 180 references. The full text is freely available (open access, CC BY 4.0). Funded by: Ministry of Science and Higher Education of the Russian Federation.
Abstract (original language)
Since the discovery of penicillin in 1928, more than a thousand antibiotics have been introduced into medical practice. Initially, the introduction of antibiotics revolutionized the treatment of infectious diseases. However, as antibiotics have been used repeatedly, scientists and clinicians have observed serious adverse consequences, most notably the emergence of bacterial resistance to antimicrobial agents. Of particular concern are multidrug-resistant pathogens, which are resistant to multiple antibiotic classes. As of 2024, antibiotic-resistant bacteria are directly responsible for approximately 1.27 million deaths worldwide. Thus, in response, possible new antibacterial agents are under investigation, including bacteriophages and the associated bacteriolytic enzymes. According to the World Health Organization (WHO), phage-based drugs are leading nonclassical antibiotics currently in clinical trials. Meanwhile, endolysins, as bacteriolytic phage enzymes, have emerged as promising antibacterial agents. This study reviews the key achievements and mechanisms of action of bacteriophage endolysins against bacterial infections, including biofilms, and discusses the therapeutic potential of endolysins in combating antibiotic resistance. Finally, the combined use of endolysins with other biomolecules and the application of artificial intelligence to address antimicrobial-resistant infections are also discussed.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Institute of Biochemistry and Physiology of Plants and Microorganisms - Subdivision of the Federal State Budgetary Research Institution Saratov Federal Scientific Centre of the Russian Academy of Sciences (IBPPM RAS), 4…
Funding
- Ministry of Science and Higher Education of the Russian Federation
Cite
APA
Guliy, O. I., & Karavaeva, O. A. (2026). Endolysins and Their Potential in Combating Bacterial Multidrug Resistance. Frontiers in Bioscience-Elite, 18(2). https://doi.org/10.31083/fbe44070
Vancouver
Guliy OI, Karavaeva OA. Endolysins and Their Potential in Combating Bacterial Multidrug Resistance. Frontiers in Bioscience-Elite. 2026;18(2). doi:10.31083/fbe44070
BibTeX
@article{Guliy2026,
author = {Guliy, Olga I and Karavaeva, Olga A},
title = {Endolysins and Their Potential in Combating Bacterial Multidrug Resistance},
journal = {Frontiers in Bioscience-Elite},
year = {2026},
volume = {18},
number = {2},
doi = {10.31083/fbe44070}
}
EUVIMED